Eurand drug delivery
This article was originally published in The Tan Sheet
Executive Summary
Italian firm launches AdvaTab fast dissolve technology for products that "dissolve rapidly in the mouth without the need for chewing or water." Tablets dissolve within 15-30 seconds for "convenience, compliance and, as a result, improved efficacy," company says. AdvaTab incorporates a proprietary external lubrication system and can be combined with Eurand's Microcaps taste-masking technology. Firm estimates worldwide sales of over $1 bil. for drugs with fast-dissolve technology; among Eurand's top-selling OTCs are acetaminophen, pseudoephedrine, ibuprofen...
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.